All Stories

  1. Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure
  2. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short‐Bowel Syndrome: A Review of Recent Literature
  3. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria
  4. Outcome of kidney function in adults on long-term home parenteral nutrition for chronic intestinal failure
  5. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey
  6. Intestinal failure in adults: Recommendations from the ESPEN expert groups
  7. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
  8. Reversal of intestinal failure associated liver disease fibrosis in a patient receiving long term home parenteral nutrition
  9. Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure
  10. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey
  11. Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy
  12. Home parenteral nutrition (HPN) in patients with post-bariatric surgery complications
  13. Revised ESPEN Clinical Classification of Chronic Intestinal Failure: From 16 to 8 Categories
  14. Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy
  15. Corrigendum to “ESPEN guidelines on chronic intestinal failure in adults” [Clin Nutr 35 (2) (2016) 247–307]
  16. Development of home artificial nutrition in Italy over a seven year period: 2005–2012
  17. Functional lipidomics in patients on home parenteral nutrition: Effect of lipid emulsions
  18. Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group
  19. Reply, Letter to the Editor – Primary thromboprophylaxis for adult patients on home parenteral nutrition: A comment on the 2016 ESPEN guideline
  20. Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy
  21. Reply to Letter to the Editor – Intestinal failure definition and classification comments
  22. Definitions of intestinal failure and the short bowel syndrome
  23. ESPEN guidelines on chronic intestinal failure in adults
  24. ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy
  25. Prospective study of catheter-related central vein thrombosis in home parenteral nutrition patients with benign disease using serial venous Doppler ultrasound
  26. Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition
  27. Iodine status in intestinal failure in adults
  28. Plasma citrulline after small bowel transplantation: effect of time from transplantation, acute cellular rejection, and renal failure
  29. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults
  30. Indications and Timing for Intestinal/Multivisceral Transplantation
  31. Correction: Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
  32. Effect of Age on Native Kidney Function after Adult Intestinal Transplants on Long-Term Follow-up
  33. Iodine nutrition in adults on long-term home parenteral nutrition
  34. Long-Term Endoscopic Follow-up in Small Bowel Transplant Recipients: Single-Center Series
  35. Renal function in patients on long-term home parenteral nutrition and in intestinal transplant recipients
  36. Outcome Indicators for Home Parenteral Nutrition Care
  37. Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition
  38. Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
  39. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients
  40. Intravenous Lipids in Home Parenteral Nutrition
  41. Disease-Related Intestinal Transplant in Adults: Results From a Single Center
  42. Isolated Intestinal Transplant for Chronic Intestinal Pseudo-Obstruction in Adults: Long-Term Outcome
  43. Operative Endoscopy for Treatment of Native Rectal Post-Transplantation Lymphoproliferative Disease After Adult Small Bowel Transplantation: A Case Report
  44. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide – Analyses from a randomised, placebo-controlled study
  45. Extracorporeal Photopheresis for Chronic GVHD
  46. Induction therapy in adult intestinal transplantation: reduced incidence of rejection with “2-dose” alemtuzumab protocol
  47. Mortality After Steroid-Resistant Acute Cellular Rejection and Chronic Rejection Episodes in Adult Intestinal Transplants: Report From a Single Center in Induction/Preconditioning Era
  48. Development of quality of care interventions for adult patients on home parenteral nutrition (HPN) with a benign underlying disease using a two-round Delphi approach
  49. Quality of care for cancer patients on home parenteral nutrition: development of key interventions and outcome indicators using a two-round Delphi approach
  50. Assessment of Quality of Life on Home Parenteral Nutrition and After Intestinal Transplantation Using Treatment-Specific Questionnaires
  51. Outcome on home parenteral nutrition for benign intestinal failure: A review of the literature and benchmarking with the European prospective survey of ESPEN
  52. Home parenteral nutrition: An international benchmarking exercise
  53. The Authors' reply: Table 1
  54. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation
  55. Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient
  56. Comprehensive Surgical Intestinal Rescue and Transplantation Program in Adult Patients: Bologna Experience
  57. Daclizumab and Alemtuzumab as Induction Agents in Adult Intestinal and Multivisceral Transplantation: Rejection and Infection Rates in 40 Recipients During the Early Postoperative Period
  58. Intestinal Transplantation
  59. ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients
  60. Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab
  61. Parvovirus B19 Infection Localized in the Intestinal Mucosa and Associated with Severe Inflammatory Bowel Disease
  62. The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure
  63. Survival of Patients Identified as Candidates for Intestinal Transplantation: A 3-Year Prospective Follow-Up
  64. Vitamin A and Vitamin E Isoforms Stability and Peroxidation Potential of All-In-One Admixtures for Parenteral Nutrition
  65. Collaborative Strategies to Reduce Mortality and Morbidity in Patients With Chronic Intestinal Failure Including Those Who Are Referred for Small Bowel Transplantation
  66. Cholestasis Induced by Total Parenteral Nutrition
  67. Management of intestinal failure in Europe. A questionnaire based study on the incidence and management
  68. Italian Experience in Adult Clinical Intestinal and Multivisceral Transplantation: 6 Years Later
  69. Rejection Episodes and 3-Year Graft Survival Under Sirolimus and Tacrolimus Treatment After Adult Intestinal Transplantation
  70. Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period
  71. Steroids in intestinal transplantation
  72. Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience
  73. Prevalence of home artificial nutrition in Italy in 2005: A survey by the Italian Society for Parenteral and Enteral Nutrition (SINPE)
  74. Effect of Total Enterectomy, Pancreatectomy, and Portal Vein Ligation on Liver Function and Histology: A Case Report
  75. Recovery From Liver Dysfunction After Adult Isolated Intestinal Transplantation Without Liver Grafting
  76. Total parenteral nutrition-related gastroenterological complications
  77. Monitoring of patients on home parenteral nutrition (HPN) in Europe: A questionnaire based study on monitoring practice in 42 centres
  78. Candidates for Intestinal Transplantation: A Multicenter Survey in Europe
  79. Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1
  80. Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth
  81. Quality of Life on Home Parenteral Nutrition or After Intestinal Transplantation
  82. Results of Intestinal and Multivisceral Transplantation in Adult Patients: Italian Experience
  83. Role of citrulline in rejection monitoring after bowel transplantation
  84. Surgical Approach to Complicated Intestinal Failure for Benign Disease in Adult Patients: Transplantation or Surgical Rehabilitation?
  85. Octreotide in the outpatient therapy of cirrhotic chylous ascites: A case report
  86. Twenty-Seven Consecutive Intestinal and Multivisceral Transplants in Adult Patients: A 4-Year Clinical Experience
  87. Bone mineral density in patients on home parenteral nutrition: a follow-up study
  88. Intestinal Transplantation for Chronic Intestinal Pseudo-Obstruction in Adult Patients
  89. Erratum to “Effects of the September 2003, 28 blackout in Italy in patients on home parenteral nutrition (HPN)”
  90. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure
  91. The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease
  92. Three-year experience in clinical intestinal transplantation
  93. Effects of the September 28 2003 blackout in Italy in patients on home parenteral nutrition (HPN)
  94. Peroxidation potential of lipid emulsions after compounding in all-in-one solutions
  95. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre
  96. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100.000 catheter days
  97. Prevalence of bone disease in patients on home parenteral nutrition
  98. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition
  99. Cost-benefit of home artificial nutrition regulation
  100. Clinical Nutrition is not a teenager any longer
  101. Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial
  102. Timely nutrition screen for hospital patients
  103. Bone turnover in short-term and long-term home parenteral nutrition for benign disease
  104. Nutrition parentérale à domicile chez l'adulte : enquête multicentrique en Europe en 1993 ESPEN — Home Artificial Nutrition Working Group
  105. Bone turnover in patients on home parenteral nutrition: alongitudinal observation by biochemical markers
  106. Chronic intestinal pseudo-obstruction
  107. Cost-benefit and cost-effectiveness analysis ofhome artificial nutrition: reappraisal of available data
  108. Possible role of structural lipids in artificial nutrition: comparison of a linoleic acid-based with an oleic acid-based enteral formula in humans
  109. Nutritional status of patients undergoing ileal pouch-anal anastomosis
  110. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease
  111. Urinary zinc excretion in Crohn's disease
  112. Circadian rhythm of gastric inhibitory polypeptide (GIP) in man
  113. Adrenergic modulation of gastric inhibitory polypeptide secretion in man
  114. Gastric Inhibitory Polypeptide Release after Oral Glucose: Relationship to Glucose Intolerance, Diabetes Mellitus, and Obesity
  115. Effect of Somatostatin on Fasting and Glucose-Stimulated Gastric Inhibitory Polypeptide Release in Man